Skip to content
HowShorted

TENET HEALTHCARE CORP short interest in 2020

In 2020, TENET HEALTHCARE CORP's disclosed short interest ran from 8.18% of shares outstanding on 15 Jan 2020 to 4.79% on 31 Dec 2020, a change of -3.39 percentage points. The year's high was 9.15% on 31 Mar 2020 and its low 4.79% on 31 Dec 2020, averaging 7.80% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.65 days on 14 Feb 2020. Full history: TENET HEALTHCARE CORP.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TENET HEALTHCARE CORP in 2020

2020 in figures

Start of year
8.18% (15 Jan 2020)
End of year
4.79% (31 Dec 2020)
Change
-3.39 pp
High
9.15% (31 Mar 2020)
Low
4.79% (31 Dec 2020)
Average
7.80%
Highest days to cover
11.65 (14 Feb 2020)
SEC filings marked
10

Every report in 2020

TENET HEALTHCARE CORP short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20208.18%8.16results (8-K)
31 Jan 20208.20%9.22
14 Feb 20207.81%11.65
28 Feb 20207.69%4.4210-K filed, results (8-K)
13 Mar 20208.43%3.64
31 Mar 20209.15%2.60
15 Apr 20209.12%2.65results (8-K)
30 Apr 20208.88%4.75
15 May 20208.67%3.7310-Q filed, results (8-K)
29 May 20209.14%4.86
15 Jun 20208.29%4.44
30 Jun 20209.02%3.73
15 Jul 20208.49%6.17
31 Jul 20207.64%4.87
14 Aug 20207.41%4.9810-Q filed, results (8-K)
31 Aug 20207.58%8.73
15 Sep 20207.52%7.98
30 Sep 20207.69%4.66
15 Oct 20207.42%7.11
30 Oct 20207.30%6.02results (8-K), 10-Q filed
13 Nov 20206.98%5.08
30 Nov 20206.35%9.28
15 Dec 20205.35%4.81
31 Dec 20204.79%7.31

See also: TENET HEALTHCARE CORP's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.